citric acid, anhydrous has been researched along with isoniazid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Liao, Y; Peng, SQ; Yan, XZ; Zhang, LS | 1 |
| Buys, GM; du Plessis, LH; Hamman, JH; Kotze, AF; Marais, AF | 1 |
3 other study(ies) available for citric acid, anhydrous and isoniazid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Metabonomics profile of urine from rats administrated with different treatment period of isoniazid].
Topics: Animals; Antitubercular Agents; Biomarkers; Chemical and Drug Induced Liver Injury; Citric Acid; Citric Acid Cycle; Glucose; Isoniazid; Ketoglutaric Acids; Lipids; Magnetic Resonance Spectroscopy; Male; Metabolome; Mitochondria; Rats; Rats, Wistar; Taurine; Toxicity Tests | 2007 |
Direct compression of chitosan: process and formulation factors to improve powder flow and tablet performance.
Topics: Antitubercular Agents; Chemistry, Pharmaceutical; Chitosan; Citric Acid; Compressive Strength; Drug Compounding; Excipients; Isoniazid; Particle Size; Pectins; Powders; Solubility; Tablets; Tensile Strength | 2013 |